These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33051651)

  • 21. Low Risk of Lymphoma in Pediatric Patients Treated for Inflammatory Bowel Disease.
    Egberg MD; Zhang X; Smitherman AB; Kappelman MD
    Am J Gastroenterol; 2023 Feb; 118(2):354-359. PubMed ID: 36219181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications.
    Targownik LE; Benchimol EI; Bernstein CN; Singh H; Tennakoon A; Zubieta AA; Coward S; Jones J; Kaplan GG; Kuenzig ME; Murthy SK; Nguyen GC; Peña-Sánchez JN
    J Crohns Colitis; 2020 Oct; 14(10):1354-1363. PubMed ID: 32648579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.
    Mader O; Juillerat P; Biedermann L; Michetti P; Hruz P; Pittet V; Rogler G; Zahnd-Straumann N; Seibold F
    United European Gastroenterol J; 2021 Apr; 9(3):398-406. PubMed ID: 33203339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
    Casanova MJ; Chaparro M; Mínguez M; Ricart E; Taxonera C; García-López S; Guardiola J; López-San Román A; Iglesias E; Beltrán B; Sicilia B; Vera MI; Hinojosa J; Riestra S; Domènech E; Calvet X; Pérez-Calle JL; Martín-Arranz MD; Aldeguer X; Rivero M; Monfort D; Barrio J; Esteve M; Márquez L; Lorente R; García-Planella E; de Castro L; Bermejo F; Merino O; Rodríguez-Pérez A; Martínez-Montiel P; Van Domselaar M; Alcaín G; Domínguez-Cajal M; Muñoz C; Gomollón F; Fernández-Salazar L; García-Sepulcre MF; Rodríguez-Lago I; Gutiérrez A; Argüelles-Arias F; Rodriguez C; Rodríguez GE; Bujanda L; Llaó J; Varela P; Ramos L; Huguet JM; Almela P; Romero P; Navarro-Llavat M; Abad Á; Ramírez-de la Piscina P; Lucendo AJ; Sesé E; Madrigal RE; Charro M; García-Herola A; Pajares R; Khorrami S; Gisbert JP
    Inflamm Bowel Dis; 2020 Mar; 26(4):606-616. PubMed ID: 31504569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
    Samadder NJ; Valentine JF; Guthery S; Singh H; Bernstein CN; Leighton JA; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Burt RW; Curtin K; Smith KR
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1807-1813.e1. PubMed ID: 30267862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
    Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
    Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No Change in Surgical and Hospitalization Trends Despite Higher Exposure to Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease in the Québec Provincial Database From 1996 to 2015.
    Verdon C; Reinglas J; Coulombe J; Gonczi L; Bessissow T; Afif W; Vutcovici M; Wild G; Seidman EG; Bitton A; Brassard P; Lakatos PL
    Inflamm Bowel Dis; 2021 Apr; 27(5):655-661. PubMed ID: 32676662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
    Sourianarayanane A; Garg G; Smith TH; Butt MI; McCullough AJ; Shen B
    J Crohns Colitis; 2013 Sep; 7(8):e279-85. PubMed ID: 23158500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database.
    McAuliffe ME; Lanes S; Leach T; Parikh A; Faich G; Porter J; Holick C; Esposito D; Zhao Y; Fox I
    Curr Med Res Opin; 2015; 31(9):1655-64. PubMed ID: 26135040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
    Rubin DT; Griffith J; Zhang Q; Hepp Z; Keshishian A
    Inflamm Bowel Dis; 2021 Jul; 27(8):1201-1209. PubMed ID: 33107564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment strategy changes for inflammatory bowel diseases in biologic era: results from a multicenter cohort in Japan, Far East 1000.
    Taida T; Ohta Y; Kato J; Ogasawara S; Ohyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Iino Y; Kumagai J; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Okabe S; Saito H; Kato K; Uehara H; Mizumoto H; Koma Y; Azemoto R; Ito K; Kamezaki H; Mandai Y; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N
    Sci Rep; 2023 Aug; 13(1):13555. PubMed ID: 37604846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Anti-Tumor Necrosis Factor Therapy With Mortality Among Veterans With Inflammatory Bowel Disease.
    Cohen-Mekelburg S; Wallace BI; Van T; Wiitala WL; Govani SM; Burns J; Lipson R; Yun H; Hou J; Lewis JD; Dominitz JA; Waljee AK
    JAMA Netw Open; 2021 Mar; 4(3):e210313. PubMed ID: 33646314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN.
    Atia O; Harel S; Ledderman N; Greenfeld S; Kariv R; Dotan I; Balicer R; Silverman B; Matz E; Levi Z; Waterman M; Fried I; Rowe JM; Turner D
    J Crohns Colitis; 2022 Jun; 16(5):786-795. PubMed ID: 34791097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD.
    Barnes EL; Hanson JS; Regueiro MD; Saha S; Sands BE; Rubin DT; Dubinsky MC; Siegel CA; Gazis DR; Crawford JM; Long MD
    J Clin Gastroenterol; 2022 Jul; 56(6):529-535. PubMed ID: 34115661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends of Utilization of Tumor Necrosis Factor Antagonists in Children With Inflammatory Bowel Disease: A Canadian Population-Based Study.
    El-Matary W; Leung S; Tennakoon A; Benchimol EI; Bernstein CN; Targownik LE
    Inflamm Bowel Dis; 2020 Jan; 26(1):134-138. PubMed ID: 31323083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

  • 38. Should biologic agents be stopped before surgery for inflammatory bowel disease?
    Zaghiyan K; McGovern D; Fleshner P
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):269-72. PubMed ID: 25366845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Review and Meta-Analysis: Preoperative Vedolizumab and Postoperative Complications in Patients with IBD.
    Moosvi Z; Duong JT; Bechtold ML; Nguyen DL
    South Med J; 2021 Feb; 114(2):98-105. PubMed ID: 33537791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.
    Murthy SK; Begum J; Benchimol EI; Bernstein CN; Kaplan GG; McCurdy JD; Singh H; Targownik L; Taljaard M
    Gut; 2020 Feb; 69(2):274-282. PubMed ID: 31196874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.